It is also known as a proto‐oncogene, whose expression is linked to anti‐apoptotic functions in several types of cancer, including AML, through the activation of AKT/mTORC1/RPS6 signaling (Li et al, 2010; Pellegrino et al, 2014; Sun et al, 2014). The gene discussed is RPS6; the disease is acute myeloid leukemia.